217 related articles for article (PubMed ID: 32424881)
21. Intravoxel Incoherent Motion Magnetic Resonance Imaging for Prediction of Induction Chemotherapy Response in Locally Advanced Hypopharyngeal Carcinoma: Comparison With Model-Free Dynamic Contrast-Enhanced Magnetic Resonance Imaging.
Guo B; Ouyang F; Ouyang L; Huang X; Guo T; Lin S; Liu Z; Zhang R; Yang SM; Chen H; Hu QG
J Magn Reson Imaging; 2021 Jul; 54(1):91-100. PubMed ID: 33576125
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic Efficacy of Contrast-Enhanced MRI in Detecting Residual or Recurrent Hepatocellular Carcinoma After Transarterial Chemoembolization: A Systematic Review and Meta-analysis.
Liu HF; Zou LQ; Lu XR; Sheng Y; Wang Q; Ding JL; Shi L; Liu SQ; Xing W
J Magn Reson Imaging; 2020 Oct; 52(4):1019-1028. PubMed ID: 31675170
[TBL] [Abstract][Full Text] [Related]
23. Prediction of tumor response via a pretreatment MRI radiomics-based nomogram in HCC treated with TACE.
Kong C; Zhao Z; Chen W; Lv X; Shu G; Ye M; Song J; Ying X; Weng Q; Weng W; Fang S; Chen M; Tu J; Ji J
Eur Radiol; 2021 Oct; 31(10):7500-7511. PubMed ID: 33860832
[TBL] [Abstract][Full Text] [Related]
24. Radiologic-pathologic analysis of contrast-enhanced and diffusion-weighted MR imaging in patients with HCC after TACE: diagnostic accuracy of 3D quantitative image analysis.
Chapiro J; Wood LD; Lin M; Duran R; Cornish T; Lesage D; Charu V; Schernthaner R; Wang Z; Tacher V; Savic LJ; Kamel IR; Geschwind JF
Radiology; 2014 Dec; 273(3):746-58. PubMed ID: 25028783
[TBL] [Abstract][Full Text] [Related]
25. Applying arterial enhancement fraction (AEF) texture features to predict the tumor response in hepatocellular carcinoma (HCC) treated with Transarterial chemoembolization (TACE).
Mao X; Guo Y; Wen F; Liang H; Sun W; Lu Z
Cancer Imaging; 2021 Aug; 21(1):49. PubMed ID: 34384496
[TBL] [Abstract][Full Text] [Related]
26. Imaging Predictors of Survival in Patients with Single Small Hepatocellular Carcinoma Treated with Transarterial Chemoembolization.
Park C; Kim JH; Kim PH; Kim SY; Gwon DI; Chu HH; Park M; Hur J; Kim JY; Kim DJ
Korean J Radiol; 2021 Feb; 22(2):213-224. PubMed ID: 32901464
[TBL] [Abstract][Full Text] [Related]
27. Serial diffusion-weighted MRI in patients with hepatocellular carcinoma: Prediction and assessment of response to transarterial chemoembolization. Preliminary experience.
Mannelli L; Kim S; Hajdu CH; Babb JS; Taouli B
Eur J Radiol; 2013 Apr; 82(4):577-82. PubMed ID: 23246330
[TBL] [Abstract][Full Text] [Related]
28. Advanced imaging techniques in the therapeutic response of transarterial chemoembolization for hepatocellular carcinoma.
Yang K; Zhang XM; Yang L; Xu H; Peng J
World J Gastroenterol; 2016 May; 22(20):4835-47. PubMed ID: 27239110
[TBL] [Abstract][Full Text] [Related]
29. Prediction of transarterial chemoembolization refractoriness in patients with hepatocellular carcinoma using imaging features of gadoxetic acid-enhanced magnetic resonance imaging.
Byun J; Kim SY; Kim JH; Kim MJ; Yoo C; Shim JH; Lee SS
Acta Radiol; 2021 Dec; 62(12):1548-1558. PubMed ID: 33197329
[TBL] [Abstract][Full Text] [Related]
30. Post-TACE changes in ADC histogram predict overall and transplant-free survival in patients with well-defined HCC: a retrospective cohort with up to 10 years follow-up.
Shaghaghi M; Aliyari Ghasabeh M; Ameli S; Ghadimi M; Hazhirkarzar B; Rezvani Habibabadi R; Khoshpouri P; Pandey A; Pandey P; Kamel IR
Eur Radiol; 2021 Mar; 31(3):1378-1390. PubMed ID: 32894356
[TBL] [Abstract][Full Text] [Related]
31. Role of diffusion-weighted imaging in evaluating therapeutic efficacy after transcatheter arterial chemoembolization for hepatocellular carcinoma.
Kubota K; Yamanishi T; Itoh S; Murata Y; Miyatake K; Yasunami H; Morio K; Hamada N; Nishioka A; Ogawa Y
Oncol Rep; 2010 Sep; 24(3):727-32. PubMed ID: 20664980
[TBL] [Abstract][Full Text] [Related]
32. Hepatocellular carcinoma: short-term reproducibility of apparent diffusion coefficient and intravoxel incoherent motion parameters at 3.0T.
Kakite S; Dyvorne H; Besa C; Cooper N; Facciuto M; Donnerhack C; Taouli B
J Magn Reson Imaging; 2015 Jan; 41(1):149-56. PubMed ID: 24415565
[TBL] [Abstract][Full Text] [Related]
33. Postintervention Interleukin-6 (IL-6) Level, Rather than the Pretreatment or Dynamic Changes of IL-6, as an Early Practical Marker of Tumor Response in Hepatocellular Carcinoma Treated with Transarterial Chemoembolization.
Wu Y; Fan W; Xue M; Zhong B; Zhang S; Wang Y; Yao W; Zhao Y; Li J
Oncologist; 2019 Dec; 24(12):e1489-e1495. PubMed ID: 31249138
[TBL] [Abstract][Full Text] [Related]
34. 25-OH-vitamin D deficiency identifies poor tumor response in hepatocellular carcinoma treated with transarterial chemoembolization.
Wu YQ; Fan WZ; Xue M; Guo J; Wei JL; Wang Y; Yao W; Zhao Y; Li JP
Clin Transl Oncol; 2020 Jan; 22(1):70-80. PubMed ID: 31183764
[TBL] [Abstract][Full Text] [Related]
35. Esophageal carcinoma: Intravoxel incoherent motion diffusion-weighted MRI parameters and histopathological correlations.
Zhu S; Wei Y; Gao F; Li L; Liu Y; Huang Z; Tang H; Zheng D; Wei X; Sun T; Song B
J Magn Reson Imaging; 2019 Jan; 49(1):253-261. PubMed ID: 29734492
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of efficacy of transcatheter arterial chemoembolization combined with computed tomography-guided radiofrequency ablation for hepatocellular carcinoma using magnetic resonance diffusion weighted imaging and computed tomography perfusion imaging: A prospective study.
Shao GL; Zheng JP; Guo LW; Chen YT; Zeng H; Yao Z
Medicine (Baltimore); 2017 Jan; 96(3):e5518. PubMed ID: 28099329
[TBL] [Abstract][Full Text] [Related]
37. Preoperative histogram analysis of intravoxel incoherent motion (IVIM) for predicting microvascular invasion in patients with single hepatocellular carcinoma.
Li H; Zhang J; Zheng Z; Guo Y; Chen M; Xie C; Zhang Z; Mei Y; Feng Y; Xu Y
Eur J Radiol; 2018 Aug; 105():65-71. PubMed ID: 30017300
[TBL] [Abstract][Full Text] [Related]
38. Unresectable hepatocellular carcinoma: serial early vascular and cellular changes after transarterial chemoembolization as detected with MR imaging.
Kamel IR; Liapi E; Reyes DK; Zahurak M; Bluemke DA; Geschwind JF
Radiology; 2009 Feb; 250(2):466-73. PubMed ID: 19188315
[TBL] [Abstract][Full Text] [Related]
39. Preoperative MRI features and clinical laboratory indicators for predicting the early therapeutic response of hepatocellular carcinoma to transcatheter arterial chemoembolization combined with High-intensity focused ultrasound treatment.
Zhang H; He X; Yu J; Song W; Liu X; Liu Y; Zhou J; Guo D
Br J Radiol; 2019 Jul; 92(1099):20190073. PubMed ID: 31166700
[TBL] [Abstract][Full Text] [Related]
40. Radiomics analysis of pretreatment MRI in predicting tumor response and outcome in hepatocellular carcinoma with transarterial chemoembolization: a two-center collaborative study.
Liu QP; Yang KL; Xu X; Liu XS; Qu JR; Zhang YD
Abdom Radiol (NY); 2022 Feb; 47(2):651-663. PubMed ID: 34918174
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
